Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California. more
Time Frame | OMIC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.25% | -2.12% | -3% |
1-Month Return | -9.82% | -3.42% | -0.73% |
3-Month Return | 19.06% | -11.13% | 2.87% |
6-Month Return | 103.01% | -5.74% | 7.17% |
1-Year Return | 59.33% | 3.97% | 25.31% |
3-Year Return | -93.76% | 1.05% | 28.38% |
5-Year Return | -97.62% | 34.37% | 81.89% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | 765.00K | 2.91M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":26.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 350.00K | 639.00K | 1.13M | 789.00K | 3.47M | [{"date":"2019-12-31","value":10.09,"profit":true},{"date":"2020-12-31","value":18.42,"profit":true},{"date":"2021-12-31","value":32.66,"profit":true},{"date":"2022-12-31","value":22.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (350.00K) | (639.00K) | (1.13M) | (24.00K) | (558.00K) | [{"date":"2019-12-31","value":-35000000,"profit":false},{"date":"2020-12-31","value":-63900000,"profit":false},{"date":"2021-12-31","value":-113300000,"profit":false},{"date":"2022-12-31","value":-2400000,"profit":false},{"date":"2023-12-31","value":-55800000,"profit":false}] |
Gross Margin | - | - | - | (3.14%) | (19.17%) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3.14,"profit":false},{"date":"2023-12-31","value":-19.17,"profit":false}] |
Operating Expenses | 12.77M | 27.53M | 61.28M | 93.46M | 102.24M | [{"date":"2019-12-31","value":12.49,"profit":true},{"date":"2020-12-31","value":26.93,"profit":true},{"date":"2021-12-31","value":59.93,"profit":true},{"date":"2022-12-31","value":91.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (12.77M) | (27.53M) | (61.28M) | (93.49M) | (102.80M) | [{"date":"2019-12-31","value":-1277000000,"profit":false},{"date":"2020-12-31","value":-2753400000,"profit":false},{"date":"2021-12-31","value":-6127900000,"profit":false},{"date":"2022-12-31","value":-9348700000,"profit":false},{"date":"2023-12-31","value":-10280100000,"profit":false}] |
Total Non-Operating Income/Expense | 892.00K | (624.00K) | (38.01M) | 5.22M | 15.36M | [{"date":"2019-12-31","value":5.81,"profit":true},{"date":"2020-12-31","value":-4.06,"profit":false},{"date":"2021-12-31","value":-247.48,"profit":false},{"date":"2022-12-31","value":33.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (12.32M) | (27.95M) | (98.77M) | (90.88M) | (94.82M) | [{"date":"2019-12-31","value":-1232400000,"profit":false},{"date":"2020-12-31","value":-2794500000,"profit":false},{"date":"2021-12-31","value":-9877100000,"profit":false},{"date":"2022-12-31","value":-9087900000,"profit":false},{"date":"2023-12-31","value":-9482000000,"profit":false}] |
Income Taxes | 17.00K | 718.00K | 118.00K | (2.61M) | 9.08M | [{"date":"2019-12-31","value":0.19,"profit":true},{"date":"2020-12-31","value":7.91,"profit":true},{"date":"2021-12-31","value":1.3,"profit":true},{"date":"2022-12-31","value":-28.72,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (12.34M) | (28.66M) | (98.89M) | (88.27M) | (103.90M) | [{"date":"2019-12-31","value":-1234100000,"profit":false},{"date":"2020-12-31","value":-2866300000,"profit":false},{"date":"2021-12-31","value":-9888900000,"profit":false},{"date":"2022-12-31","value":-8827100000,"profit":false},{"date":"2023-12-31","value":-10390200000,"profit":false}] |
Income From Continuous Operations | (12.32M) | (27.95M) | (63.57M) | (90.88M) | (92.67M) | [{"date":"2019-12-31","value":-1232400000,"profit":false},{"date":"2020-12-31","value":-2794500000,"profit":false},{"date":"2021-12-31","value":-6357200000,"profit":false},{"date":"2022-12-31","value":-9087900000,"profit":false},{"date":"2023-12-31","value":-9267200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (12.34M) | (28.66M) | (98.89M) | (88.27M) | (94.82M) | [{"date":"2019-12-31","value":-1234100000,"profit":false},{"date":"2020-12-31","value":-2866300000,"profit":false},{"date":"2021-12-31","value":-9888900000,"profit":false},{"date":"2022-12-31","value":-8827100000,"profit":false},{"date":"2023-12-31","value":-9482000000,"profit":false}] |
EPS (Diluted) | (0.52) | (2.05) | (1.35) | (1.27) | (1.31) | [{"date":"2019-12-31","value":-51.54,"profit":false},{"date":"2020-12-31","value":-205.28,"profit":false},{"date":"2021-12-31","value":-135,"profit":false},{"date":"2022-12-31","value":-127,"profit":false},{"date":"2023-12-31","value":-131,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
OMIC | |
---|---|
Cash Ratio | 6.46 |
Current Ratio | 7.37 |
Quick Ratio | 6.67 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OMIC | |
---|---|
ROA (LTM) | -24.27% |
ROE (LTM) | -51.61% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OMIC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.34 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.66 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OMIC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 18.39 |
P/B | 0.41 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 0.77 |
Singular Genomics Systems Inc (OMIC) share price today is $19.55
Yes, Indians can buy shares of Singular Genomics Systems Inc (OMIC) on Vested. To buy Singular Genomics Systems Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OMIC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Singular Genomics Systems Inc (OMIC) via the Vested app. You can start investing in Singular Genomics Systems Inc (OMIC) with a minimum investment of $1.
You can invest in shares of Singular Genomics Systems Inc (OMIC) via Vested in three simple steps:
The 52-week high price of Singular Genomics Systems Inc (OMIC) is $23.41. The 52-week low price of Singular Genomics Systems Inc (OMIC) is $5.34.
The price-to-earnings (P/E) ratio of Singular Genomics Systems Inc (OMIC) is
The price-to-book (P/B) ratio of Singular Genomics Systems Inc (OMIC) is 0.41
The dividend yield of Singular Genomics Systems Inc (OMIC) is 0.00%
The market capitalization of Singular Genomics Systems Inc (OMIC) is $50.08M
The stock symbol (or ticker) of Singular Genomics Systems Inc is OMIC